Tenon Medical, Inc.

For the period ended Dec 31, 2025. Filed Mar 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 27, 2026

TNON$1.75+6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form 10-K Summary

N/A.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Tenon Medical, Inc.
Date: March 27, 2026	By:	/s/ Steven M. Foster
		Steven M. Foster
		Chief Executive Officer and President
		(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 27, 2026.

Richard Ginn
Name	Position	Date
/s/ Steven M. Foster	Chief Executive Officer and President, Director	March 27, 2026
Steven M. Foster	(Principal Executive Officer)
/s/ Richard Ginn	Chief Technology Officer and Director	March 27, 2026
/s/ Kevin Williamson	Chief Financial Officer	March 27, 2026
Kevin Williamson	(Principal Financial and Accounting Officer)
/s/ Richard Ferrari	Director	March 27, 2026
Richard Ferrari
/s/ Ivan Howard	Director	March 27, 2026
Ivan Howard
/s/ Kristine M. Jacques	Director	March 27, 2026
Kristine M. Jacques
/s/ Robert K. Weigle	Director	March 27, 2026
Robert K. Weigle
/s/ Stephen H. Hochschuler, M.D	Director	March 27, 2026
Stephen H. Hochschuler, M.D

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.